|
PPIB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.636130E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.831600E-02 |
| Normal-vs-Stage2 |
9.595000E-01 |
| Normal-vs-Stage3 |
1.075280E-03 |
| Normal-vs-Stage4 |
3.921000E-03 |
| Stage1-vs-Stage2 |
1.873840E-01 |
| Stage1-vs-Stage3 |
3.902200E-02 |
| Stage1-vs-Stage4 |
7.835800E-02 |
| Stage2-vs-Stage3 |
9.139500E-03 |
| Stage2-vs-Stage4 |
1.802350E-02 |
| Stage3-vs-Stage4 |
8.390200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.657200E-03 |
| Normal-vs-AfricanAmerican |
1.435030E-01 |
| Normal-vs-Asian |
4.648400E-02 |
| Caucasian-vs-AfricanAmerican |
8.862400E-01 |
| Caucasian-vs-Asian |
7.661400E-01 |
| AfricanAmerican-vs-Asian |
7.920800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.844800E-01 |
| Normal-vs-Female |
4.079200E-03 |
| Male-vs-Female |
3.033800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.929600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.198200E-03 |
| Normal-vs-Age(61-80Yrs) |
6.055800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.220000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.015200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.170600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.773600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.727600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.740000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.400000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.92269977716819E-10 |
| Classical-VS-Follicular |
2.76570000001808E-06 |
| Classical-VS-Other |
4.839600E-01 |
| Classical-VS-Normal |
7.576400E-04 |
| Tall-VS-Follicular |
1.64657176782157E-12 |
| Tall-VS-Other |
4.354300E-02 |
| Tall-VS-Normal |
4.69957406323829E-13 |
| Follicular-VS-Other |
3.233600E-01 |
| Follicular-VS-Normal |
6.630300E-02 |
| Other-VS-Normal |
5.736200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.005800E-01 |
| Normal-vs-N1 |
9.155900E-02 |
| N0-vs-N1 |
1.778240E-01 |
|
|
